# Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer

> **NCT03622827** · PHASE2 · UNKNOWN · sponsor: **Nanjing Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **COMBINATION_PRODUCT:** Chemoradiotherapy+ Endostar

## Key facts

- **NCT ID:** NCT03622827
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-31
- **Primary completion:** 2023-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03622827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03622827, "Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03622827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*